FDA Approval Summary: Nivolumab for the Treatment of...

  • Main
  • 2017 / 04
  • FDA Approval Summary: Nivolumab for the Treatment of...
The Oncologist 2017 / 04

FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma

Kasamon, Yvette L., de Claro, R. Angelo, Wang, Yaping, Shen, Yuan Li, Farrell, Ann T., Pazdur, Richard
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2017-0004
Date:
April, 2017
File:
PDF, 250 KB
english, 2017
Conversion to is in progress
Conversion to is failed